Last reviewed · How we verify
Intravaginal application of estradiol cream
Intravaginal application of estradiol cream is a Small molecule drug developed by Stephanie Wang Zuo. It is currently in Phase 2 development.
At a glance
| Generic name | Intravaginal application of estradiol cream |
|---|---|
| Sponsor | Stephanie Wang Zuo |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections (PHASE2)
- Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intravaginal application of estradiol cream CI brief — competitive landscape report
- Intravaginal application of estradiol cream updates RSS · CI watch RSS
- Stephanie Wang Zuo portfolio CI
Frequently asked questions about Intravaginal application of estradiol cream
What is Intravaginal application of estradiol cream?
Intravaginal application of estradiol cream is a Small molecule drug developed by Stephanie Wang Zuo.
Who makes Intravaginal application of estradiol cream?
Intravaginal application of estradiol cream is developed by Stephanie Wang Zuo (see full Stephanie Wang Zuo pipeline at /company/stephanie-wang-zuo).
What development phase is Intravaginal application of estradiol cream in?
Intravaginal application of estradiol cream is in Phase 2.